Showing results (491-500 of 817) with videos related to
Sort By:
Pageof 82
Current Computer-Aided Drug Design|December 6, 2018
Molecular Docking Studies of Methamphetamine and Amphetamine- Related Derivatives as an Inhibitor against Dopamine ReceptorKobra Foroughi, Mehdi Khaksari, Asghar ShayanniaCurrent Computer-Aided Drug Design|December 22, 2018
Towards further Understanding the Structural Requirements of Combretastatin- like Chalcones as Inhibitors of Microtubule PolymerizationNaveen Dhingra, Anand Kar, Rajesh SharmaCurrent Computer-Aided Drug Design|March 23, 2018
Structural Optimization of Mangiferin Binding to Cancer Molecular Targets: A Guide for Synthetic DerivatizationBamigboye J Taiwo, Olujide O Olubiyi, Fanie R van HeerdenCurrent Computer-Aided Drug Design|March 23, 2018
Exploring the Influence of Mutation on Transthyretin Aggregation in Heart DiseaseAnkita Sharma, Monu, Sagarika BiswasCurrent Computer-Aided Drug Design|January 18, 2019
Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro CytotoxicityRavi Jarapula, Vishnu N Badavath, Shriram Rekulapally, et al.Current Computer-Aided Drug Design|October 2, 2010
How can we explain the stability of conjugated hydrocarbon-and heterosubstituted networks by topological descriptors?Haruo HosoyaCurrent Computer-Aided Drug Design|October 2, 2010
On the contribution of molecular topology to drug design and discoveryJ Gálvez, R García-DoménechCurrent Computer-Aided Drug Design|October 2, 2010
Optimization methods for virtual screening on novel computational architecturesHoracio Pérez-Sánchez, Wolfgang WenzelCurrent Computer-Aided Drug Design|September 3, 2010
Conformational diseases: structural studies of aggregation of polyglutamine proteinsElena Papaleo, Gaetano InvernizziCurrent Computer-Aided Drug Design|June 17, 2010
Systematic generation of chemical structures for rational drug design based on QSAR modelsKimito Funatsu, Tomoyuki Miyao, Masamoto ArakawaPageof 82